Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ALSSF OTCMKTS:ATGSF NASDAQ:CARA OTCMKTS:HDALF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeALSSFAlsea$2.82+9.3%$2.48$1.89▼$3.50N/AN/A6,289 shs210 shsATGSFAutogrill$5.63$5.63$5.63▼$7.46N/AN/A933 shsN/ACARACara Therapeutics$15.19$8.13▼$19.08$24.33M0.4123,271 shs237,144 shsHDALFHaidilao International$2.01+2.6%$2.03$1.30▼$2.67N/AN/A7,980 shs5,079 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceALSSFAlsea0.00%+9.30%+8.88%+39.95%-18.55%ATGSFAutogrill0.00%0.00%0.00%0.00%0.00%CARACara Therapeutics0.00%0.00%0.00%+8.57%+55.01%HDALFHaidilao International0.00%+3.49%+1.69%-4.96%+17.54%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationALSSFAlseaN/AN/AN/AN/AN/AN/AN/AN/AATGSFAutogrillN/AN/AN/AN/AN/AN/AN/AN/ACARACara Therapeutics0.3754 of 5 stars0.00.00.04.20.60.80.0HDALFHaidilao InternationalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceALSSFAlsea 0.00N/AN/AN/AATGSFAutogrill 0.00N/AN/AN/ACARACara Therapeutics 0.00N/AN/AN/AHDALFHaidilao International 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookALSSFAlseaN/AN/AN/AN/AN/AN/AATGSFAutogrillN/AN/AN/AN/AN/AN/ACARACara Therapeutics$7.14M0.00N/AN/A$12.58 per share0.00HDALFHaidilao InternationalN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateALSSFAlseaN/A$1.062.66∞N/AN/AN/AN/A7/21/2025 (Estimated)ATGSFAutogrillN/AN/A0.00∞N/AN/AN/AN/AN/ACARACara Therapeutics-$118.51M-$21.01N/AN/AN/A-1,099.76%-367.97%-107.43%N/AHDALFHaidilao InternationalN/AN/A0.00∞N/AN/AN/AN/A8/25/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthALSSFAlseaN/AN/AN/AN/AN/AATGSFAutogrillN/AN/AN/AN/AN/ACARACara TherapeuticsN/AN/AN/AN/AN/AHDALFHaidilao InternationalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioALSSFAlseaN/AN/AN/AATGSFAutogrillN/AN/AN/ACARACara TherapeuticsN/A4.774.71HDALFHaidilao InternationalN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipALSSFAlsea22.50%ATGSFAutogrillN/ACARACara Therapeutics44.66%HDALFHaidilao InternationalN/AInsider OwnershipCompanyInsider OwnershipALSSFAlseaN/AATGSFAutogrillN/ACARACara Therapeutics3.10%HDALFHaidilao InternationalN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableALSSFAlsea76,047N/AN/ANot OptionableATGSFAutogrill31,155N/AN/ANot OptionableCARACara Therapeutics804.57 million4.43 millionOptionableHDALFHaidilao International89,233N/AN/ANot OptionableHDALF, CARA, ALSSF, and ATGSF HeadlinesRecent News About These CompaniesHaidilao Establishes Nomination Committee to Strengthen Board GovernanceJune 20, 2025 | tipranks.comHDALF Haidilao International Holding Ltd.June 4, 2025 | seekingalpha.comChinese hotpot chain Haidilao fetches $88M in Vietnam revenueMarch 31, 2025 | msn.comHaidilao operator Super Hi slips back into the red with $15.5 million loss in Q4March 28, 2025 | straitstimes.comSDBS Keeps Their Buy Rating on Haidilao International Holding (HDALF)March 26, 2025 | markets.businessinsider.comHaidilao International's 2024 Net Profit Helped by Delivery BusinessMarch 26, 2025 | marketwatch.comHaidilao International Shares Climb After 2024 Earnings ResultsMarch 26, 2025 | marketwatch.comEmerging Trends in Chinese Consumption: Insights from Pop Mart, Haidilao, and Nongfu SpringMarch 21, 2025 | sohu.comSChinese restaurant apologizes after video of diners urinating into hotpot broth goes viralMarch 14, 2025 | msn.comDBS Sticks to Its Buy Rating for Haidilao International Holding (HDALF)February 6, 2025 | markets.businessinsider.comHow a dropout became one of Singapore’s richest billionaires with Haidilao hotpot chainJanuary 25, 2025 | msn.comHow billionaire couple behind Haidilao hotpot chain became one of Singapore’s richestJanuary 24, 2025 | msn.comHong Kong stocks log biggest loss in 2 months on China outlook, trade tensionsJanuary 11, 2025 | msn.comHaidilao International Holding Ltd. (HDALF)January 11, 2025 | finance.yahoo.comHaidilao Strengthens Financial Ties with SubsidiaryDecember 10, 2024 | markets.businessinsider.comOmni takes first H160 frpm GDHF as lessor builds portfolioNovember 12, 2024 | flightglobal.comFLuckin Coffee, Haidilao and other China chains may be suffering indigestion from regional expansionOctober 29, 2024 | businesstimes.com.sgBThe Chinese Dining Chains Making a Play for World DominationOctober 25, 2024 | sixthtone.comSBeneath the bonnet: The case for Yihai International, Jollyes and EM healthcareOctober 24, 2024 | portfolio-adviser.comPHaidilao International Holdings: Strong Market Position and Strategic Initiatives Drive ‘Buy’ RatingOctober 17, 2024 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeHDALF, CARA, ALSSF, and ATGSF Company DescriptionsAlsea OTCMKTS:ALSSF$2.82 +0.24 (+9.30%) As of 07/8/2025 10:10 AM EasternAlsea, S.A.B. de C.V. operates restaurants in Latin America and Europe. It operates fast food, coffee shops, casual food, and family restaurants under the Domino's Pizza, Starbucks, Burger King, Chili's, PF Chang's, Italianni's, The Cheesecake Factory, Vips, The gate, Foster's Hollywood, Archies, Ginos, T.G.I. Fridays, Vips Europe, Vips Smart, Ole Mole, and Clay Hear brands. The company was incorporated in 1997 and is headquartered in Mexico City, Mexico.Autogrill OTCMKTS:ATGSF$5.63 0.00 (0.00%) As of 03/7/2024Autogrill S.p.A., through its subsidiaries, provides food and beverage services for travelers in North America, Italy, and other European countries. It also sells fuel. The company operates through concessions at airports, motorway rest stops, and railway stations; and in shopping centers, trade fairs, and cultural attractions, as well as on high streets. It manages a portfolio of approximately 300 brands directly or under license. The company was founded in 1947 and is headquartered in Rozzano, Italy. Autogrill S.p.A. is a subsidiary of Dufry AG.Cara Therapeutics NASDAQ:CARACara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chronic pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. It also develops Oral difelikefalin, which is in Phase II/III clinical trial to treat chronic pruritus with notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; Vifor Fresenius Medical Care Renal Pharma Ltd. development and commercialization of KORSUVA injection for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.Haidilao International OTCMKTS:HDALF$2.01 +0.05 (+2.55%) As of 07/9/2025 02:47 PM EasternHaidilao International Holding Ltd., an investment holding company, engages in the restaurant operation and delivery businesses. The company through operates through Restaurant Operation, Delivery Business, and Sales of Condiment Products and Food Ingredients segments. It also operates a Haidilao branded Chinese cuisine restaurant that offers hot pot cuisine. In addition, the company is involved in the technology; hotel operation; property investment management and consulting; and trading businesses. It owns and operates restaurants in Mainland China, Hong Kong, Macau, and Taiwan. The company was founded in 1994 and is headquartered in Beijing, the People's Republic of China. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nebius Group: Up 385%, Analysts Say It’s Still a Bargain BigBear.ai: Why a 90% Rally Could Be Just the Start Will Oracle's Cloud and AI Deals Propel It to New Highs? Enovix Shares Hit 6-Month High; Long-Term Highs to Follow Tesla Stock Could Accelerate on New EV Tax Legislation SoundHound Rises as Short Sellers Exit and AI Demand Grows Alphabet: Technical Momentum Is Starting to Turn Boeing's Rebound Is Well Underway—But Is It Too Late? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
